Poster Abstract Session:
130. CMV and Transplantation
Saturday, October 22, 2011: 11:45 AM-1:45 PM
Room: Poster Hall B1

Learning Objectives:


Target Audience: Academicians

Topical Category: O. Transplant infectious diseases

Tracks: Adult ID


Antiviral Prophylaxis versus Pre-emptive Therapy to Prevent CMV Infection and Related Death in Liver Transplantation: A Retrospective Cohort Study with Propensity Score Matching
Chung-Jong Kim, MD ; Heejung Son, MS ; Young-Eun Kim ; Myoung Soo Kim, MD, PhD ; Shin Hwang, MD, PhD ; Ji Il Kim, MD, PhD ; Sang Il Kim, MD

Paradoxical Increasing Cytomegalovirus Antigenemia Titer during Preemptive Ganciclovir Therapy in Hematopoietic Stem Cell Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes
So-Youn Park, MD ; Song Mi Moon, MD ; Hyun Jung Park, MD ; Sang-Oh Lee, MD ; Sang-Ho Choi, MD, PhD ; Yang Soo Kim, MD, PhD ; Jun Hee Woo, MD, PhD ; Heungsup Sung, MD, PhD ; Mi-Na Kim, MD, PhD ; Dae-Young Kim, MD ; Jung-Hee Lee, MD, PhD ; Je-Hwan Lee, MD, PhD ; Kyoo-Hyung Lee, MD, PhD ; Sung-Han Kim, MD, PhD

Baseline Absolute Lymphocyte Count is a Risk Factor for CMV Disease after Orthotopic Liver Transplantation
Natalie E. Nierenberg, MD, MPH ; Debra D. Poutsiaka, MD, PhD ; Jennifer Chow, MD, MS ; Richard Rohrer, MD ; Jeffrey Cooper, MD ; Richard Freeman, MD ; Karen Curreri, RN, CCTC ; David Snydman, MD, FIDSA

CMV-specific CD4 and CD8 Responses Are Sensitive Markers for New Onset CMV Infections Among D+/R- Lung Transplant Patients (LTx Pts) and Identify Those Who Are Protected from CMV Relapse after Antiviral Therapy 
Cornelius Clancy, MD ; Cory Lutgen ; Jin Yu ; Jeff Hester, PhD ; Linda Flebbe-Rehwaldt ; D Mitsani, MD ; Ryan K. Shields, PharmD ; M. Hong Nguyen, MD

CME Credits:

ACPE Credits:

ACPE Number:

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.